Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
GBP | Fiscal Year Ending | | Latest |
(in millions) | Mar-15 | Mar-16 | Mar-17 | Mar-18 | Mar-19 | Mar-20 | Mar-21 | Mar-22 | Mar-23 | Mar-24 | | Sep-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 227 | 63 | 313 | 53 | 229 | (153) | 482 | 623 | 176 | 236 | | 133 |
% Growth | NA | -72.2% | 395.3% | -83.1% | 333.3% | -166.8% | -415.0% | 29.3% | -71.7% | 34.1% | | |
| | | | | | | | | | | | |
Cost of Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Gross Profit | 227 | 63 | 313 | 53 | 229 | (153) | 482 | 623 | 176 | 236 | | 133 |
% Revenue | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | | 100.0% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
General and Admin | (20) | (24) | (26) | (22) | (26) | (15) | (25) | (32) | (29) | (30) | | (31) |
Other Inc / (Exp) | (1) | (2) | (1) | (7) | (5) | (2) | 2 | 3 | (0) | 3 | | (2) |
Total Operating Exp | (21) | (25) | (27) | (29) | (30) | (18) | (23) | (29) | (29) | (27) | | (33) |
| | | | | | | | | | | | |
Operating Income | 206 | 38 | 286 | 24 | 199 | (170) | 458 | 594 | 147 | 209 | | 100 |
% Revenue | 90.6% | 59.8% | 91.4% | 44.9% | 86.8% | 111.4% | 95.2% | 95.4% | 83.4% | 88.4% | | 75.1% |
| | | | | | | | | | | | |
Interest Expense | (1) | (2) | (2) | (2) | (2) | (2) | (3) | (2) | 2 | (7) | | 2 |
Pre-tax Income | 205 | 36 | 285 | 22 | 197 | (172) | 456 | 592 | 149 | 201 | | 102 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | 3 | 5 | 6 | 4 | 1 | (1) | 10 | 19 | (6) | 2 | | 5 |
Net Income to Company | 208 | 41 | 290 | 27 | 198 | (173) | 466 | 611 | 143 | 204 | | 107 |
% Margin | 91.5% | 65.0% | 92.7% | 50.2% | 86.6% | 113.1% | 96.8% | 98.1% | 81.1% | 86.3% | | 80.6% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | 208 | 41 | 290 | 27 | 198 | (173) | 466 | 611 | 143 | 204 | | 107 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 208 | 41 | 290 | 27 | 198 | (173) | 466 | 611 | 143 | 204 | | 107 |
% Margin | 91.5% | 65.0% | 92.7% | 50.2% | 86.6% | 113.1% | 96.8% | 98.1% | 81.1% | 86.3% | | 80.6% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 3.77 | 0.75 | 5.28 | 0.48 | 3.61 | (3.15) | 8.49 | 11.21 | 2.63 | 3.75 | | 1.97 |
Diluted EPS (Continuing Ops) | 3.71 | 0.73 | 5.18 | 0.47 | 3.55 | (3.15) | 8.38 | 11.02 | 2.59 | 3.69 | | 1.94 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 55.10 | 55.16 | 54.93 | 54.92 | 54.92 | 54.88 | 54.87 | 54.50 | 54.29 | 54.39 | | 54.12 |
WA Diluted Shares Out. | 55.97 | 56.19 | 55.96 | 55.90 | 55.88 | 54.88 | 55.62 | 55.49 | 55.17 | 55.24 | | 54.95 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 205 | 36 | 285 | 22 | 197 | (172) | 456 | 592 | 149 | 201 | | 102 |
Addback: Net Interest Expense | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | (2) | 7 | | (2) |
Addback: Other Non Operating Expenses, Total | (1) | (1) | 1 | 1 | (1) | 1 | 1 | 0 | 0 | (6) | | (1) |
Addback: Depreciation & Amortization | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | | 1 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | (0) | (0) | (0) | 6 | 5 | 0 | (3) | (4) | 1 | 4 | | 4 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Adjusted EBITDA | 208 | 40 | 287 | 31 | 204 | (168) | 457 | 592 | 150 | 208 | | 104 |
% Margin | 91.5% | 63.1% | 91.7% | 58.7% | 89.3% | 110.1% | 94.9% | 95.0% | 84.8% | 87.8% | | 78.0% |
| | | | | | | | | | | | |
Adjusted EBIT | 208 | 40 | 287 | 30 | 203 | (170) | 456 | 591 | 148 | 206 | | 103 |
% Margin | 91.4% | 62.8% | 91.7% | 57.2% | 88.9% | 110.9% | 94.7% | 94.8% | 84.2% | 87.4% | | 77.2% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 208 | 41 | 290 | 27 | 198 | (173) | 466 | 611 | 143 | 204 | | 107 |
Addback: Unusual Items | 2 | 3 | 0 | 6 | 5 | 0 | (3) | (4) | 1 | 4 | | 4 |
Less: Tax Benefit of Unusual Items (26%) | (1) | (1) | (0) | (2) | (1) | 0 | 1 | 1 | (0) | (1) | | (1) |
Adjusted Net Income | 209 | 43 | 290 | 31 | 202 | (173) | 464 | 609 | 144 | 207 | | 110 |
% Margin | 92.2% | 68.3% | 92.8% | 58.5% | 88.3% | 113.1% | 96.3% | 97.7% | 81.7% | 87.5% | | 82.8% |